Strontium Citrate

gluten free strontium citrate

Strontium is a common earth element which is easily incorporated in the bones and stimulates new bone formation and delays bone resorption. Therefore, it is a near ideal natural remedy to improve low bone density.

In a number of clinical studies, strontium was shown to reduce frequency of vertebral, hip and peripheral bone fractures.


Potential side effects:

  •     Diarrhea
  •     Nausea
  •     Gastrointestinal upset
  •     Transient joint pain
  •     Slightly increased risk of venous blood clots


Potential drug interactions:

  •     Quinolone antibiotics – ciprofloxacin, levofloxacin
  •     Tetracycline antibiotics – tetracycline, minocycline, doxycycline
  •     Bisphosphonates – Fosamax, Actonel, Boniva


Relative contraindications:

  •     Pregnancy
  •     Lactation
  •     Decreased kidney function
  •     History of blood clots in the veins (venous thromboembolism, e.g., deep vein thrombosis or pulmonary embolism).
  •     Blood disorders that increase the risk of blood clots in the veins (e.g., antiphospholipid syndrome, factor V Leiden mutation)
  •     Young age (less than 25 years)


Contents: 100 caps


To view supplement facts click here


Dosage information:
The daily dose of strontium citrate should not exceed 700 mg a day. Strontium citrate should be taken on an empty stomach with a glass of water at least 30 minutes before a meal. Strontium and calcium as well as strontium and magnesium should not be taken together. Take them at least 2 hours apart from each other.

Selected references:


Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004;350:459-468.


Meunier PJ, Slosman DO, Delmas PD, et al. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis: a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab. 2002;87(5):2060-2066.


Reginster JY, et al. Strontium ranelate reduces fractures in osteoporotic women. J Clin Endocrinol Metab. 2005; 90(5):2816-2822.




These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

All information contained on this website is intended for informational and educational purposes only, and is not intended nor suited to be a replacement or substitute for professional medical treatment or for professional medical advice relative to a specific medical question or condition.

Related Supplements


  • Osteoporosis/Osteopenia
  • Periodontal Disease

Leave a Reply

Your email address will not be published. Required fields are marked *